ATTD: Advanced Technologies and Treatments for Diabetes

ATTD on UNLOK

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:
* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.
* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).

Whether you're a specialist, researcher, or industry leader, hit subscribe.

Subscribe Listen in podnod RSS feed Show website

21 episodes
Updated Today

Episodes21

Newest first

Today · 29 min
Practical implementation of inhaled insulin in clinical practice
In our new series, The Role of Inhaled Insulin, host Dr David Ahn looks at the practical implementation of inhaled insulin in clinical practice. He is joined by Dr Irl Hirsch. They discuss: Where inhaled insulin fits today within the overall insulin therapy landscape The best candidates for inhaled insulin in routine clinical practice Key clinical factors to guide decision-making Practical first steps to initiating inhaled insulin Approaches to titration Monitoring strategies, particularly regarding pulmonary safety and glycemic outcomes Shared decision-making and engaging patients Dr Irl Hirsch is Professor of Medicine, in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington School of Medicine. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
July 28 · 16 min
Addressing Clinicians’ FAQs on Insulin Therapy
In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy. They discuss: The most common mistakes or misconceptions in basal insulin initiation and management Intensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinations Leveraging technologies to improve insulin adherence and outcomes Managing hypoglycemia concerns and achieving glycemic targets Addressing psychological and behavioral barriers to insulin use in everyday clinical practice Dr Elena Toschi is Assistant Professor of Medicine at Harvard Medical School. She’s also Director of the Young Adult Program and a member of the Diabetes Technology Program at the Joslin Diabetes Center. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
July 14 · 14 min
Personalised Approaches for Complex Populations
In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations. They discuss: Why personalization is particularly important in insulin therapy The patient groups most in need of a tailored approach How comorbidities or frailty influence insulin decision-making Guidelines, flexibility, and local solutions Dr Peters is a Professor of Medicine at the Keck School of Medicine of USC, and Director of the USC Clinical Diabetes Programs. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
June 30 · 18 min
Overcoming Barriers to Insulin Adherence
In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients. They discuss: The barriers most misunderstood by clinicians Communication and motivational interviewing with patients Emotional burden and fear of hypoglycemia Practical strategies clinicians can use to support patients more effectively The role of the wider diabetes healthcare team Diana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
June 16 · 18 min
Preventing & Managing Hypoglycemia
In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education. They discuss: Why hypoglycemia remains a major concern in insulin therapy Key risk factors to keep in mind Clinical signs or patient-reported symptoms Prevention strategies Importance of patient education Balancing glycemic targets with hypoglycemia risk Prof. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
June 2 · 17 min
Smart Tools & Technology for Better Insulin Outcomes
In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support. They discuss: The new technologies making the biggest difference in insulin therapy today The role of smart pens, connected devices, and apps Biggest clinical impact - including adherence, titration and outcomes Accessibility of these tools in real-world practice Advisor role of AI The promising future of technology in insulin therapy and a functional cure Professor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
May 19 · 14 min
Fixed-Ratio Combinations (FRCs) in Practice
In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations. They discuss: What exactly fixed-ratio combinations are and the problems they tackle Identifying patient candidates and timelines for starting FRCs Meaningful benefits of FRCs compared with basal insulin alone Concerns and limitations of FRCs How guideline recommendations currently position FRCs in diabetes management Dr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
May 5 · 18 min
Safe & Effective Insulin Titration Strategies
In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient. They discuss: The importance of titration in successful insulin therapy Barriers to titration, including patient self-management How clinicians can collaborate with patients in their titration journey The importance of language used by clinicians Practical tips for simplifying titration in busy clinical settings Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
April 21 · 19 min
Identifying Patients for Insulin Initiation in T2D
In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes. They discuss: When clinicians should consider insulin for patients with T2D Addressing concerns of weight gain with insulin ADA/EASD recommendations Barriers to insulin therapy and Type 2 diabetes Advice on communication with patients Dr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
April 7 · 18 min
Principles of Basal Insulin Therapy in Type 2 Diabetes
In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use. He is joined by Dr Giulio Romeo. They discuss: The role of basal insulin in normal physiology and why it matters in Type 2 diabetes Goals of basal insulin therapy What makes new basal insulins different Current guidelines and recommendations for basal insulin therapy Alternatives to basal insulin therapy Tips for safe and effective initiation and titration Dr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
March 14 · 22 min
Advancements in Type 1 Diabetes, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies. Join us as we summarize key takeaways from these thought-provoking presentations: Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
March 14 · 19 min
ATTD AI School for Clinicians, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use. Join us as we summarize key takeaways from these thought-provoking presentations: Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
March 14 · 24 min
Continuous Glucose Monitoring Outside the Traditional Areas, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas, exploring innovative applications of CGM beyond its conventional use in diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews Non-invasive Glucose Monitoring – Dr. Lutz Heinemann CGM Use in Clinical Trials – Prof. Pratik Choudhary This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
March 14 · 24 min
Cardiovascular Disease in Type 1 Diabetes, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes. While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population. Join us as we summarize key takeaways from these thought-provoking presentations: • Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel • Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell • Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard • Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com
March 14 · 16 min
Refining Care of Type 1 Diabetes, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into Refining Care of Type 1 Diabetes, featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Refining Care of Type 1 Diabetes – Dr. Lori Laffel Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
March 14 · 17 min
Managing Overweight & Obesity in T1D, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into Managing Overweight & Obesity in Type 1 Diabetes, featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes. As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond glycemic control. This session explores the role of behavioral, nutritional, and therapeutic approaches in supporting sustainable weight management while maintaining optimal diabetes outcomes. Join us as we summarize key takeaways from these thought-provoking presentations: • The Role of Psychological Interventions in Promoting Sustainable Weight Loss – Alon Liberman • Essential Nutrition Support for GLP-1/GIP Therapy Success – Dr. Adrian Brown • Beyond Glycemia: Addressing Overweight and Obesity in Type 1 Diabetes – Prof. Lia Bally This episode is an essential listen for endocrinologists, diabetologists, dietitians, and healthcare professionals involved in diabetes care looking to better understand multidisciplinary approaches to weight management in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com
March 14 · 21 min
Adjunct Therapies with Automated Insulin Delivery, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into Adjunct Therapies with Automated Insulin Delivery, featuring new clinical evidence on combining automated insulin delivery (AID) systems with adjunct pharmacological therapies to improve outcomes in Type 1 diabetes. As diabetes technology continues to evolve, researchers are exploring how therapies traditionally used in Type 2 diabetes-such as SGLT-2 inhibitors and GLP-1 receptor agonists-may complement automated insulin delivery systems to optimize glycemic control and potentially improve cardiometabolic outcomes. Join us as we summarize key takeaways from these thought-provoking presentations: • ADJUST T1D Study – Design and Glycemic Outcome – Dr. Viral N. Shah (United States of America) presents the study design and early glycemic outcomes of the ADJUST T1D trial, evaluating the impact of adjunct therapies alongside automated insulin delivery. • ADJUST T1D Study – Cardiovascular Outcomes – Dr. Janet K. Snell-Bergeon • Concurrent Use of AID with SGLT-2 – Dr. Ahmad Haidar • Real-Life Data on GLP Use in Type 1 Diabetes – Associate Professor Francisco J. Pasquel This episode is an essential listen for endocrinologists, diabetologists, clinical researchers, and healthcare professionals involved in diabetes technology looking to understand emerging strategies that combine automated insulin delivery with adjunct pharmacological therapies to enhance diabetes management. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com
March 13 · 21 min
ATTD Yearbook Session, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into the Scientific Plenary Session: ATTD Yearbook Session, featuring a comprehensive overview of the most important advances in diabetes technology, treatments, and care over the past year. Join us as we summarize key takeaways from these thought-provoking presentations: • Continuous and Intermittent Glucose Monitoring – Professor Jennifer Sherr (United States of America) • Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan Lal (United States of America) • New Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester (Germany) • Closed-Loop, Decision Support, and Artificial Intelligence – Dr. Mark Clements (United States of America) examines advances in automated insulin delivery systems and AI-supported diabetes management. • Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman highlights the expanding role of digital tools in diabetes prevention and care. • Technology and Pregnancy – Jennifer M. Yamamoto (Canada) reviews the use of diabetes technologies to support glucose management during pregnancy. • Diabetes Technology and Therapy in the Pediatric Age Group – Prof. David M. Maahs (United States of America) discusses technological and therapeutic advances in pediatric diabetes care. • Advances in Exercise and Nutrition as Therapy in Diabetes – Prof. Michael C. Riddell (Canada) explores the evolving role of lifestyle interventions supported by technology. • Primary Care and Diabetes Technologies and Treatments – Dr. Gregg D. Simonson (United States of America) examines how innovations in diabetes care are being integrated into primary care settings. • Use of Technologies at the Advanced Age – Dr. Anna Kahkoska (United States of America) discusses the challenges and opportunities of implementing diabetes technologies in older adults. • The Real “Real World”: Overcoming Practical Barriers and Disparities in Diabetes Technology – Dr. Ananta Addala (United States of America) highlights real-world challenges in access and implementation. • Diabetes Technology in the Hospital – Tim Hropot (Slovenia) reviews the role of diabetes technologies in inpatient care. • Impact of Diabetes Technologies on Psychosocial Outcomes – Alon Liberman (Israel) discusses how technological advances affect quality of life and psychosocial wellbeing. • Immune Intervention and Beta Cell Replacement Therapies in Type 1 Diabetes – Prof. Desmond Schatz (United States of America) reviews emerging therapeutic approaches aimed at modifying disease progression. • Obesity and Diabetes – Dr. Viral N. Shah (United States of America) examines the evolving relationship between obesity and diabetes management. • Emerging Trends in MASLD and MASH – Prof. Satish K. Garg (USA) explores new insights into metabolic liver disease and its links to diabetes. • Virtual Clinics for Diabetes Care – Prof. Satish K. Garg discusses the growing role of telemedicine and virtual care models. • New Medications for the Treatment of Diabetes – Prof. Satish K. Garg reviews emerging pharmacological therapies shaping the future of diabetes treatment. This episode is an essential listen for endocrinologists, diabetologists, researchers, and healthcare professionals in diabetes care looking to stay up to date with the most important technological, therapeutic, and clinical developments presented at ATTD 2026. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com
March 13 · 22 min
Debate: HbA1c vs CGM as the Gold Standard, ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into Debate: HbA1c and Not CGM Should Be the Gold Standard to Evaluate Glucose Control, featuring a dynamic exchange of perspectives on the most accurate method for assessing glucose control in diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Pro – Dr. Elizabeth Selvin Con – Dr. Richard M. Bergenstal Moderator – Dr. Irl B. Hirsch This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking insights into the ongoing debate between HbA1c and Continuous Glucose Monitoring (CGM) in evaluating glucose control. Gain a deeper understanding of the arguments for and against each method, and the implications for diabetes management. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
March 13 · 12 min
What Else Is New? ATTD 2026 Conference Catch-Up
In this episode of ATTD 2026 Conference Catch-Up, we dive into What Else Is New? Featuring the latest advancements in the treatment and monitoring of Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Adjunctive Treatment with GLP/GIPS for Patients with Type 1 Diabetes: Consensus Report and Guidelines for Safer Use – Prof. Satish Garg An International Consensus on Screening and Monitoring Early-stage Type 1 Diabetes: A Roadmap to European Implementation – Online First Release – Dr. Sufyan Hussain This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the newest consensus guidelines and the future of screening and treatment strategies for Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com